KRASG12V/HLA-A*02:01 CAR T Cells in Solid Tumors
2026-08-07
Shao and colleagues developed B9 CAR T cells that recognize the KRASG12V peptide presented by HLA-A*02:01, addressing the specificity problem that has limited CAR T-cell therapy for solid tumors. Activity against tumor cells, patient-derived organoids, and multiple pancreatic cancer xenograft models supports further preclinical development, while the study also highlights the importance of matching both mutation and HLA status.
Ivermectin: Broad-Spectrum Anti-Parasitic in Tumor Research
2026-08-07
Ivermectin's high purity and broad-spectrum anti-parasitic activity make it indispensable for both parasitology and advanced translational oncology research. This article details robust experimental workflows, innovative applications in tumor microenvironment studies, and actionable troubleshooting strategies backed by recent discoveries on immune evasion and stemness in pancreatic cancer.
Ribonuclease R: Unlocking Circular RNA Mechanisms in Inflamm
2026-08-06
This article explores how Ribonuclease R (RNase R) (20 U/μL) reshapes translational research on circular RNA, DNA damage, and inflammatory pathology. Bridging recent mechanistic advances in pulpitis with strategic protocol guidance, it provides actionable insights for experimental design, biomarker discovery, and clinical translation. By contrasting APExBIO's RNase R with conventional workflows and integrating new evidence, the discussion charts an advanced course for RNA structure-function studies in inflammation and tissue repair.
Cy5 amine (non-sulfonated): Technical Use and Protocol Guide
2026-08-06
Cy5 amine (non-sulfonated) addresses the need for a bright, photostable fluorescence microscopy dye compatible with organic solvent-based biomolecule labeling workflows. It is unsuitable for direct aqueous labeling or clinical diagnostics, requiring careful solvent handling and storage to ensure reproducible results.
5-Aminolevulinic acid HCl: Applied Workflows in Heme Biosynt
2026-08-05
5-Aminolevulinic acid HCl empowers researchers to dissect heme biosynthesis and bacterial immune evasion with protocol-ready control. By leveraging APExBIO’s high-purity reagent, teams can model infection, optimize cancer workflows, and troubleshoot with precision.
Epalrestat: Aldose Reductase Inhibitor for Translational Ass
2026-08-05
Epalrestat sets a new benchmark for precision in polyol pathway and oxidative stress research, enabling researchers to dissect diabetic, neurodegenerative, and emerging cancer models with high reproducibility. Its unique solubility and bioactivity profile, underpinned by APExBIO's purity standards, empowers advanced experimental workflows and robust troubleshooting.
Purmorphamine as a Smoothened Agonist: Protocols & Advanced
2026-08-04
Purmorphamine enables precise Hedgehog pathway activation for bone regeneration, neural, and sensory research. This guide delivers actionable experimental workflows, troubleshooting strategies, and highlights cross-species insights, including olfactory modulation in honeybee models.
Zolmitriptan: 5-HT1B Receptor Agonist Workflows & Innovation
2026-08-04
Leverage Zolmitriptan as a high-purity 5-HT1B receptor agonist to advance migraine and cluster headache research workflows. This guide translates lysosomal biology insights and practical protocol enhancements into actionable solutions for robust, reproducible results.
C34 TLR4 Inhibitor: Precision Workflows in Inflammatory Rese
2026-08-03
C34 stands apart as a highly selective TLR4 inhibitor, empowering researchers to dissect inflammatory signaling in macrophages and enterocytes with unrivaled specificity. Its robust performance in both in vitro and in vivo assays makes it an essential tool for translational studies in neuroinflammation and necrotizing enterocolitis.
KN-62: Selective CaMKII Inhibition for Calcium Signaling Stu
2026-08-03
KN-62 excels as a potent, selective CaMKII inhibitor for dissecting calcium signaling pathways and cellular responses. Its unique mechanism and proven efficacy enable reproducible studies in insulin secretion, cell cycle regulation, and glucose transport inhibition. APExBIO provides KN-62 with reliable purity and support, giving researchers an edge in experimental precision.
MCC950 Sodium in Endotoxemia: Experimental Workflows & Insig
2026-08-02
MCC950 sodium (CRID3 sodium salt) stands out as a high-potency, selective NLRP3 inflammasome inhibitor for dissecting inflammatory and coagulation pathways in translational models. This article details reproducible workflows, highlights key innovations from recent reference studies, and delivers actionable troubleshooting guidance for maximizing assay precision in inflammatory disease research.
Metoprolol Tartrate: β1-Adrenergic Blockade in Cardiovascula
2026-08-01
Metoprolol Tartrate offers precise β1-adrenergic blocking for cardiovascular and hematopoietic studies, enabling selective pathway dissection without off-target effects. This guide details optimized protocols, troubleshooting strategies, and insights from recent research to maximize reproducibility and translational impact.
Degarelix Acetate: GnRH Antagonist Workflows in Prostate Can
2026-07-31
Degarelix acetate empowers translational researchers with rapid, selective hormone suppression, making it a gold standard GnRH receptor antagonist for both in vitro and in vivo models. Discover protocol enhancements, troubleshooting strategies, and evidence-backed innovations to accelerate prostate cancer and endocrine pathway research.
Puromycin dihydrochloride: Protocols and QC for Cell Selecti
2026-07-31
Puromycin dihydrochloride is a robust aminonucleoside antibiotic widely used for the selective elimination of non-resistant cells in both prokaryotic and eukaryotic systems. It is best applied where precise control of protein synthesis and selection for pac gene-expressing cells is required, but extended solution storage or use outside defined concentration ranges is not recommended.
HDAC3-Mediated Regulation of TPM3 2-Hydroxyisobutyrylation i
2026-07-30
Pang et al. uncover how histone deacetylase 3 (HDAC3) modulates vasoconstriction by regulating 2-hydroxyisobutyrylation (Khib) of tropomyosin 3 at Lys141 in vascular smooth muscle cells. Their work provides mechanistic insight into epigenetic modulation of vascular contractility, highlighting a potential therapeutic target for hypertensive vascular dysfunction.
457 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page